Article

Study Raises Concerns About Accuracy of Insulin Dosing Apps

The study, conducted by the Global eHealth Unit at the Imperial College London, has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin. Does this demand an FDA oversight of the apps?

A recent study led by the Global eHealth Unit at the Imperial College London has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin.

For patients on insulin, meal-time dosing of short-acting insulin is a challenging task. There are a lot of factors that go in to deciding how much insulin to administer—anticipated carbohydrate intake, premeal blood sugar, planned activities afterwards, and more. A simple calculator app to help out seems like a no-brainer. And there are a lot of apps out there that claim to do that.

Huckvale and colleagues found 46 insulin dose calculator apps in the app stores. When they evaluated these apps, they found some pretty concerning patterns.

Read the complete article on MedpageToday: http://bit.ly/1PIpbOI

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Marry Vuong, PharmD, BCPPS
Dr Sundar Jagannath
Dr Muhammad Faizan
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Sundar Jagannath
4 experts in this video
4 experts in this video
Hadar Avihai Lev-Tov, MD
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo